Democrats Hold a Nearly 2-to-1 Advantage Over Republicans on Handling the Cost of Health Care

Poll: Cost of Health Care and Gas Top Voters’ Midterm Concerns; Democrats Hold Significant Advantage on Health Care Costs and Cost of Living

Health care costs are tied with gas as voters’ top economic concern, and voters trust Democrats more than Republicans on key issues, including health care costs and the cost of living. Meanwhile, support for Medicare-for-All has reached a new high in KFF polling — though views shift significantly when competing claims from critics and proponents are heard.

Read the news release

Overview of Public Opinion on Medicare-for-All, Other National Health Plan Proposals

This chart pack summarizes KFF polling data on public opinion on Medicare-for-all and other national health plan proposals. The latest update finds that two-thirds of the public supports Medicare-for-all, while support changes drastically as respondents hear arguments from proponents and critics.

KFF/AP Rural Voters Survey

This survey finds rural voters’ frustrations about the cost of living are growing and appear to be chipping away at Republicans’ enthusiasm to vote in the midterm elections.

health in the 2026 Midterms

Health in the 2026 Midterm Elections

See the latest from our round-up of policy research, polling and news from across KFF about election-related health care issues.

Midterm Election Update: ACA Marketplaces

More people than ever got coverage through the Affordable Care Act Marketplaces in 2025, but the expiration of enhanced premium tax credits has driven up what people pay and contributed to declining enrollment in 2026. Law and regulatory changes also tightened ACA eligibility and enrollment requirements. Public opinion of the ACA remains generally favorable, although views remain divided along partisan lines.

Explore the facts

Midterm Election Update: Vaccine Policy

Federal vaccine policy has shifted toward fewer recommended routine childhood vaccinations, more emphasis on individual decision-making, and greater skepticism about the safety and efficacy of some vaccines. The changes coincide with declining childhood vaccination rates, rising exemptions from school vaccine requirements, and a major measles resurgence.

Get the details

new and noteworthy

Analysis: Is This A Healthcare Economy?

KFF’s Business of Health: Does Europe Have the Answer on AI?

Exploring Policy Developments and Data on LGBTQ Line Utilization

Featured Videos: Are Insurers to Blame for Health System Problems?

prescription drugs

Public Views on Prescription Drug Costs: Regulation, Affordability and TrumpRx

Trump Administration’s $90 Payment to Medicare Beneficiaries May Not Offset Rising Costs

Analysis: Prices for Many Brand-Name TrumpRx Drugs Are Cheaper than the Average Price in Other Wealthy Countries, But Are Almost as Likely To Be More Expensive

Consumers who buy brand-name prescription drugs without an available generic or biosimilar at the prices available through the new TrumpRx website are about as likely to pay more as pay less for those drugs relative to the publicly listed prices available in other comparatively wealthy countries, a new KFF analysis finds.

TrumpRx: What’s the Value for Customers?

This brief examines issues that may impact consumers, especially those with private insurance, who access drug discounts through TrumpRx.

From Larry Levitt: Why Do We Hear More About High Drug Prices Than About Hospital Prices?

Women's Health survey

KFF 2026 Women’s Health Survey

For more than two decades, the KFF Women’s Health Survey has provided a nationally representative look at women’s experiences with health care in the United States. Explore the latest findings →

Women’s Health Care Affordability Challenges

As health care costs dominate the national political conversation, our 2026 KFF Women’s Health Survey shows the toll those costs are taking on women. Our new nationally representative survey of women and men ages 18–64 finds costs remain a major barrier for women, specifically — causing everything from delayed care to rationed medications to cuts in spending on basic needs.